» Articles » PMID: 11193566

Effects of HIV Protease Inhibitors on Barrier Function in the Human Intestinal Cell Line HT-29/B6

Overview
Specialty Science
Date 2001 Feb 24
PMID 11193566
Citations 7
Authors
Affiliations
Soon will be listed here.
Citing Articles

Aspartyl Protease Inhibitors as Anti-Filarial Drugs.

Beld L, Jung H, Bulman C, Rosa B, Fischer P, Janetka J Pathogens. 2022; 11(6).

PMID: 35745561 PMC: 9227574. DOI: 10.3390/pathogens11060707.


Toxicities Associated With Metformin/Ritonavir Combination Treatment in Relapsed/Refractory Multiple Myeloma.

Nathwani N, Palmer J, Synold T, Salehian B, Rosenzweig M, Sanchez J Clin Lymphoma Myeloma Leuk. 2020; 20(10):e667-e672.

PMID: 32631779 PMC: 7541704. DOI: 10.1016/j.clml.2020.05.017.


Spontaneous and cytokine-induced hole formation in epithelial cell layers: Implications for barrier function studies with the gingival cell culture, Gie-3B11, and other epithelial models.

Rybakovsky E, Buleza N, Hoxha K, DiGuilio K, McCluskey E, Friday C Trends Cell Mol Biol. 2019; 13:99-114.

PMID: 31156296 PMC: 6542284.


Development of a novel self-microemulsifying drug delivery system for reducing HIV protease inhibitor-induced intestinal epithelial barrier dysfunction.

Lei B, Zha W, Wang Y, Wen C, Studer E, Wang X Mol Pharm. 2010; 7(3):844-53.

PMID: 20349948 PMC: 2882528. DOI: 10.1021/mp100003r.


HIV protease inhibitors induce endoplasmic reticulum stress and disrupt barrier integrity in intestinal epithelial cells.

Wu X, Sun L, Zha W, Studer E, Gurley E, Chen L Gastroenterology. 2009; 138(1):197-209.

PMID: 19732776 PMC: 4644065. DOI: 10.1053/j.gastro.2009.08.054.